Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014
Saved in:
Corporate Author: | United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health |
---|---|
Format: | Book |
Language: | English |
Published: |
Washington :
U.S. Government Publishing Office,
2016
|
Subjects: | |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014.
Published: (2016) -
"Man-in-the-plant" revisited--a deceptive drug labeling practice continues : hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session, March 6, 1980
Published: (1980) -
Drug labeling in developing countries
Published: (1993) -
FDA guidance regarding the promotion of off-label uses of drugs : legal issues.
Published: (2009) -
"Man-in-the-plant" revisited--a deceptive drug labeling practice continues : hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session, March 6, 1980.
Published: (1980)